Anti-Human MIP-3?, clone 3N2D9

Anti-Human MIP-3?, clone 3N2D9
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
209-301-B51S 25 µl - -

6 - 10 Werktage*

180,00 €
 
Anti-MIP-3? was purified from clarified mouse ascetic fluid by Protein A chromatography followed... mehr
Produktinformationen "Anti-Human MIP-3?, clone 3N2D9"
Anti-MIP-3? was purified from clarified mouse ascetic fluid by Protein A chromatography followed by extensive dialysis against the buffer stated above. This antibody is specific for human MIP-3? protein. A BLAST analysis was used to suggest cross-reactivity with MIP-3? from human sources based on 100% homology with the immunizing sequence. Cross-reactivity with MIP-3? from other sources has not been determined. Protein function: Chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes. Inhibits proliferation of myeloid progenitors in colony formation assays. May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E.coli ATCC 25922 and S.aureus ATCC 29213. [The UniProt Consortium]
Schlagworte: Anti-LARC, Anti-CCL20
Hersteller: Rockland Immunochemicals
Hersteller-Nr: 209-301-B51S

Eigenschaften

Anwendung: WB
Antikörper-Typ: Monoclonal
Klon: 3N2D9
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: human
Immunogen: mature full length recombinant human MIP-3? produced in E.coli followed by hybridoma development.
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Human MIP-3?, clone 3N2D9"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen